Stoke Therapeutics (STOK) CEO Sells 10,000 Shares Under Pre-Arranged Plan
Stoke Therapeutics CEO Edward M. Kaye sold 10,000 shares for $150,000 total, according to an SEC Form 4 filing.
Episode
00:00:00
00:00:00